Moderna, IAVI to commence Phase I trial of mRNA HIV vaccine trial in Africa
The Phase I trial will analyse for safety and immunogenicity of the mRNA HIV vaccine antigen in African populations.
Clinical Trials
Latest in
Clinical Trials
Humanetics extends long Covid drug trial to more sites
The trial will analyse BIO 300’s ability to alleviate long-term pulmonary damage in Covid-19 survivors.
Imugene, City of Hope doses first subject in Phase I solid tumour trial
The trial will assess the safety and tolerability of oncolytic virus CF33-hNIS as monotherapy or along with pembrolizumab.
Avrobio reports positive data from Phase I/II cystinosis gene therapy trial
The trial is assessing the safety and efficacy of AVR-RD-04 in adults with the infantile form of cystinosis.
Calliditas initiates Phase II head and neck cancer therapy trial
The trial will analyse the impact of setanaxib plus pembrolizumab in patients with CAF-density tumours.
Fertility impact questions swirl as breast cancer clinical trials recruit younger patients
Clinical Trials Arena spoke to experts who point to how additional study design parameters can measure and alleviate fertility risk.
By
Huyabio concludes Phase I atrial fibrillation trial
The US Food and Drug Administration approved dose escalation in the Phase II HBI-3000-402 trial.
C4 Therapeutics doses first subject in Phase I/II cancer therapy trial
The trial will analyse the safety, tolerability and anti-tumour activity of CFT8634 for treating SMARCB1-perturbed cancers.